Dr. Alexandra Ahmet is a pediatric endocrinologist at CHEO, an Associate Professor of pediatrics and the program director for the pediatric endocrinology residency and fellowship programs at the University of Ottawa. Dr. Ahmet has a clinical, research and advocacy focus on patient safety with a specific emphasis on adrenal suppression in children. More recently, Dr. Ahmet has also been involved in development, implementation and evaluation of new clinical programs for adolescents with Type 1 Diabetes with a goal of providing regular patient focused education in preparation for transition to adult care, and formal evaluation of quality of life and mental health status.
The impact of limited and strategic blood glucose monitoring on metabolic control in a type 1 diabetes clinic in Central India
This study assessed whether the use of two SMBG tests per day improves glycemic control, measured by a change in HbA1c, in youth with T1D followed at the DREAM Trust (DT) in Nagpur, India.
Adrenal suppression from glucocorticoids: preventing an iatrogenic cause of morbidity and mortality in children
The intent of this review is to draw attention to this important entity and to allow the reader to create an informed and practical approach to the management of their patients at risk.
Evaluating the Low-Dose ACTH Stimulation Test in Children: Ideal Times for Cortisol Measurement
To determine optimal times to draw cortisol levels and factors predicting timing of peak cortisol levels in children undergoing LDST.
Management of Type 1 diabetes in a limited resource context: A study of the diabetes research education and management trust model in Nagpur, Central India
The DT charitable programme overcomes social status, gender inequalities and experience of social stigma to provide life-saving treatment to children with T1D in central India.
Social Determinants of Health on Glycemic Control in Pediatric Type 1 Diabetes
Measures of the SDH comprising Material and Social Deprivation were significantly associated with suboptimal glycemic control in our pediatric T1D cohort. Use of insulin pump therapy also predicted A1C and may have a moderating effect on these relationships.